GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With Pruritus
Overview of attention for article published in Clinical Gastroenterology and Hepatology, November 2022
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (93rd percentile)
-
Good Attention Score compared to outputs of the same age and source (69th percentile)
Mentioned by
- news
- 2 news outlets
- 5 X users
- patent
- 1 patent
- wikipedia
- 1 Wikipedia page
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 46 Mendeley
